Biogen Incorporated Company Profile

14:31 EDT 23rd March 2018 | BioPortfolio

Biogen, Inc. is a biopharmaceutical company principally engaged in the business of developing, manufacturing and marketing drugs for human health care. The Company currently derives revenues from sales of its AVONEX(R) (Interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis and from sales by its licensees of a number of products, including alpha interferon, hepatitis B vaccines and hepatitis B diagnostic products.


14 Cambridge Center
United States of America


Phone: 617 679 2000
Fax: 617 679 2617

News Articles [328 Associated News Articles listed on BioPortfolio]

Biogen-Aktie: Fehlschlag sollte nicht von Erfolgschancen ablenken! - Aktienanalyse

New York - Biogen-Aktienanalyse von Analyst Michael Yee von Jefferies & Co: Aktienanalyst Michael Yee vom Investmenthaus Jefferies & Co empfiehlt die Aktien des US-Biotechkonzerns Biogen Inc. (ISIN...

Biogen to Acquire Phase 2-Ready Schizophenia Drug from Pfizer

Biogen is entering neuropsychiatry drug development with a deal to acquire a schizophrenia drug candidate from Pfizer. Cambridge, MA-based Biogen (NASDAQ: BIIB) is paying Pfizer $75 million up front f...

Biogen to buy Pfizer's neurology drug in deal nearing US$600 million

Biogen Inc said on Monday it would buy Pfizer Inc's experimental treatment for cognitive impairment associated with schizophrenia in a deal whose value could near US$600 million. FILE PHOTO: A sig...

Biogen-Aktie: Potenzial wird unterschätzt!

Zürich - Biogen-Aktienanalyse von Analyst Carter Gould von der UBS: Laut einer Aktienanalyse empfiehlt der Analyst Carter Gould von der UBS die Aktien des US-Biotechkonzerns Biogen Inc. (ISIN US090.....

Biogen to Develop Alkermes' MS Candidate ALKS 8700

Biogen will develop and commercialize Alkermes’ Phase III multiple sclerosis (MS) treatment ALKS 8700, the companies said today, through an up-to-$228 million-plus collaboration designed to neutrali...

Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta

Biogen Inc and AbbVie Inc have withdrawn their multiple sclerosis drug worldwide due to safety issues, the companies said on Friday. FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachuse...

Phase II flop leaves Biogen with thinning pipeline

Biogen said yesterday it would halt development of Tysabri (natalizumab) as a potential treatment for…

Biogen Taps Biotech Vet as New CFO

Mr. Capello will lead Biogen’s Business Planning, Tax, Treasury, Internal Audit, Accounting, and Investor Relations functions.

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic.

The Biogen upstream platform is capable of delivering equivalent quality material throughout the cell line generation process. This allows us to rapidly deliver high quality biopharmaceuticals to pati...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

To determine the maximal safe daily dose of BG8962 (rCD4) which can be administered by continuous subcutaneous infusion (CSCI) over 24 hours; to determine the pharmacokinetics of BG8962 wh...

Safety and Tolerability of Repeat Courses of IM Alefacept

Previous Biogen studies have provided experience with the tolerability, immunogenicity, and efficacy of a single and multiple 12-week courses of therapy of alefacept. At this stage, experi...

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

The purpose of this study is to see if we can find a new way to test how certain Multiple Sclerosis (MS) medications work in the body and to better understand how the medicines change cert...

Pregnancy Exposure Registry for AVONEX

This is an observational, exposure-registration and follow-up study, which will be conducted in the United States (US). The AVONEX® Pregnancy Exposure Registry is designed to monitor pre...

Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy

Study phase: Phase II Investigational product, dosage, and route of administration: Ibritumomab tiuxetan ("Zevalin) is composed of a murine IgG1 monoclonal antibody (ibritumomab) covalentl...

Companies [67 Associated Companies listed on BioPortfolio]

Biogen and Sobi

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare ...

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Idec and Elan Corporation, plc

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Inc.

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hema...

Biogen Idec and Abbott

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

More Information about "Biogen Incorporated" on BioPortfolio

We have published hundreds of Biogen Incorporated news stories on BioPortfolio along with dozens of Biogen Incorporated Clinical Trials and PubMed Articles about Biogen Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biogen Incorporated Companies in our database. You can also find out about relevant Biogen Incorporated Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record